Research and Markets has announced the addition of the "Global Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The results of the Atrial Fibrillation patients study are announced in this new report Global Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017. The report provides insights into Atrial Fibrillation epidemiology, Atrial Fibrillation diagnosed patients, and Atrial Fibrillation treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Atrial Fibrillation derived from epidemiological analysis, percentage of patients diagnosed with Atrial Fibrillation, and percentage of patients treated with a therapy.

The study helps executives estimate Atrial Fibrillation market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

Key Features of the Report:

  • Atrial Fibrillation Patient Flow
  • Atrial Fibrillation Prevalence
  • Atrial Fibrillation Diagnosed Patients
  • Atrial Fibrillation Treated Patients

Key Topics Covered:

1. Atrial Fibrillation: Disease Definition

2. Global Atrial Fibrillation Patient Flow

3. Atrial Fibrillation Patient Flow in the US

4. Atrial Fibrillation Patient Flow in Europe

5. Atrial Fibrillation Patient Flow in Germany

6. Atrial Fibrillation Patient Flow in France

7. Atrial Fibrillation Patient Flow in Spain

8. Atrial Fibrillation Patient Flow in Italy

9. Atrial Fibrillation Patient Flow in UK

10. Atrial Fibrillation Patient Flow in Japan

11. Research Methodology

For more information about this report visit http://www.researchandmarkets.com/research/fbrmd2/global_atrial